Tumor-infiltrating lymphocytes, tumor-associated macrophages and HLA class 1 expression in breast cancer patients treated with neoadjuvant chemotherapy with or without zoledronic acid: A sub study of the NEOZOTAC trial

Author(s):
Groot, A.F. de; Blok, E.J.; Charehbili, A.; Engels, C.C.; Smit, V.T.H.B.M.; Dekker-Ensink, N.G.; Putter, H.; Velde, C.J.H.V. de; Liefers, G.J.; Nortier, J.W.R.; Kuppen, P.J.K. (0000-0002-0294-3251); Burg, S.H. van der; Kroep, J.R.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-12-31
Language
English
Is part of
Annals of Oncology
hdl
1887/95257